Concepedia

Linxin Teng

LT

Statistics

Publications

6

Citations

114

H-Index

6

Active since

2019

Affiliations

Nanjing University of Chinese Medicine(Current)

Linxin Teng is an author at Nanjing University of Chinese Medicine specializing in oncology, molecular oncology, and medicine.

ORCID

Publications per year

2019–2024

6

Publications

6

HYR-2 plays an anti-lung cancer role by regulating PD-L1 and Akkermansia muciniphila

Linxin Teng, Kaiyuan Wang, Weiping Chen et al. · Pharmacological Research · 2020 · 28 citations · Full text

, , +16

Highly heterogeneous-related genes of triple-negative breast cancer: potential diagnostic and prognostic biomarkers

Yiduo Liu, Linxin Teng, Shiyi Fu et al. · BMC Cancer · 2021 · 28 citations · Full text

, , +17

Optimizing component formula suppresses lung cancer by blocking DTL-mediated PDCD4 ubiquitination to regulate the MAPK/JNK pathway

Qianqian Fan, Qinwei Lu, Guiyang Wang et al. · Journal of Ethnopharmacology · 2022 · 22 citations · Full text

, , +14

Based on Integrated Bioinformatics Analysis Identification of Biomarkers in Hepatocellular Carcinoma Patients from Different Regions

Linxin Teng, Kaiyuan Wang, Yu Liu et al. · BioMed Research International · 2019 · 13 citations · Full text

, , +17

Britannin inhibits hepatocellular carcinoma development and metastasis through the GSK-3β/β-catenin signaling pathway

Qinwei Lu, Junlin Zhu, Linxin Teng et al. · Phytomedicine · 2024 · 13 citations · Full text

, , +15

1–5 of 6